Physician

Aaron Thomas Bowman, MD

According to 2025 Medicare claims, Aaron Bowman, MD (NPI: 1356430227) practices hematology/oncology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is JOHN A SHIELDS MD AND STEVEN A SCHIFF MD A PROFESSIONAL CORPORATION (NPI: 1861514580; TIN: 880152239) and primary practice location at 89511-2250. Bowman is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Bowman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 721 traditional Medicare patients, billed 123,943 HCPCS/CPT codes, and received $2,628,393 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,416 prescription claims across 211 beneficiaries totaling $4,171,671 in drug costs, led by Pomalyst (Pomalidomide). 2023 DME data shows 29 claims. Open Payments data shows 54 records totaling $1,475. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $737,281 to $2,628,393. Similarly, Part D prescription costs have risen steadily, from $536,522 to $4,171,671. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,172 and ending at $1,086.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $737,281 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $792,649 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,400,904 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,656,498 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,412,631 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,364,686 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,696,882 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,349,660 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,189,706 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,628,393 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201542663,384$737,281
201643950,557$792,649
201752767,439$1,400,904
201857585,587$1,656,498
2019650117,498$2,412,631
2020706114,081$2,364,686
2021778132,557$2,696,882
2022664114,127$2,349,660
202339841,879$1,189,706
2024721123,943$2,628,393

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.1M$4.2M2015 Drug cost: $536,522 (USD; Tot_Drug_Cst)2016 Drug cost: $789,830 (USD; Tot_Drug_Cst)2017 Drug cost: $1,388,453 (USD; Tot_Drug_Cst)2018 Drug cost: $1,735,212 (USD; Tot_Drug_Cst)2019 Drug cost: $2,750,248 (USD; Tot_Drug_Cst)2020 Drug cost: $3,164,260 (USD; Tot_Drug_Cst)2021 Drug cost: $2,899,462 (USD; Tot_Drug_Cst)2022 Drug cost: $3,408,792 (USD; Tot_Drug_Cst)2023 Drug cost: $2,136,734 (USD; Tot_Drug_Cst)2024 Drug cost: $4,171,671 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151811,185$536,522
20161881,244$789,830
20171831,336$1,388,453
20181701,121$1,735,212
20191941,212$2,750,248
20202071,285$3,164,260
20212071,246$2,899,462
20221941,141$3,408,792
2023169920$2,136,734
20242111,416$4,171,671

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$15K$29K2015 Medicare payment: $9,187 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $16,947 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $29,213 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $11,653 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,086 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $11,549 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $7,469 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,934 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,151 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R135$9,187
2016N/R122$16,947
201726176$29,213
2018N/R116$11,653
2019N/R23$3,086
2020N/R170$11,549
2021N/R121$7,469
2022N/R88$3,934
2023N/R29$1,151
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more198343$137
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more404882$96
80053Blood test, comprehensive group of blood chemicals246391$10
36415Insertion of needle into vein for collection of blood sample327597$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count355706$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide22616$489,944
ImbruvicaIbrutinib32964$463,773
JakafiRuxolitinib Phosphate24720$416,743
BrukinsaZanubrutinib29870$253,216
IbrancePalbociclib13350$197,619

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.54$1,475E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aaron Thomas Bowman, MD?

Tedicare shows public-source Medicare data for Aaron Thomas Bowman, MD (NPI 1356430227), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Thomas Bowman, MD have ACO affiliation data?

Aaron Thomas Bowman, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Aaron Thomas Bowman, MD?

Aaron Thomas Bowman, MD is linked to JOHN A SHIELDS MD AND STEVEN A SCHIFF MD A PROFESSIONAL CORPORATION (billing NPI 1861514580) in the available physician profile data.

Does Aaron Thomas Bowman, MD have Open Payments data?

Aaron Thomas Bowman, MD has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.